Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats
出版年份 2017 全文链接
标题
Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-05-30
DOI
10.1038/s41598-017-02884-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Antipsychotics-induced metabolic alterations: Focus on adipose tissue and molecular mechanisms
- (2015) Pedro Gonçalves et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Vitamin D deficiency exacerbates atypical antipsychotic-induced metabolic side effects in rats: Involvement of the INSIG/SREBP pathway
- (2015) Ruili Dang et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Acute effects of oral olanzapine treatment on the expression of fatty acid and cholesterol metabolism-related gene in rats
- (2015) Xuemei Liu et al. LIFE SCIENCES
- Betahistine co-treatment ameliorates dyslipidemia induced by chronic olanzapine treatment in rats through modulation of hepatic AMPKα-SREBP-1 and PPARα-dependent pathways
- (2015) Xuemei Liu et al. PHARMACOLOGICAL RESEARCH
- A potential mechanism underlying atypical antipsychotics-induced lipid disturbances
- (2015) H L Cai et al. Translational Psychiatry
- QoL evaluation of olanzapine for chemotherapy-induced nausea and vomiting comparing with 5-HT3 receptor antagonist
- (2014) J. Liu et al. EUROPEAN JOURNAL OF CANCER CARE
- Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways
- (2014) Jiamei Lian et al. PSYCHONEUROENDOCRINOLOGY
- Medical Costs and Hospitalizations Among Patients with Depression Treated with Adjunctive Atypical Antipsychotic Therapy: An Analysis of Health Insurance Claims Data
- (2013) Rachel Halpern et al. ANNALS OF PHARMACOTHERAPY
- Second Generation Antipsychotic-Induced Type 2 Diabetes: A Role for the Muscarinic M3 Receptor
- (2013) Katrina Weston-Green et al. CNS DRUGS
- Effects of Antipsychotic Medications on Appetite, Weight, and Insulin Resistance
- (2013) Chao Deng ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Investigation of the metabolic effects of chronic clozapine treatment on CCK-1 receptor deficient Otsuka Long Evans Tokushima Fatty (OLETF) rats
- (2013) Csaba Hegedűs et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Acute Effects of Single-Dose Olanzapine on Metabolic, Endocrine, and Inflammatory Markers in Healthy Controls
- (2013) Margaret Karolina Hahn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Le facteur de transcription ChREBP
- (2013) Fadila Benhamed et al. M S-MEDECINE SCIENCES
- Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density
- (2013) Jiamei Lian et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health
- (2013) Leah Eissing et al. Nature Communications
- Update on Typical and Atypical Antipsychotic Drugs
- (2012) Herbert Y. Meltzer Annual Review of Medicine
- Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model
- (2012) Chao Deng et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism
- (2012) Mark A. Herman et al. NATURE
- Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone
- (2012) Peter Manu et al. SCHIZOPHRENIA RESEARCH
- Atypical Antipsychotic-Induced Weight Gain
- (2011) James L. Roerig et al. CNS DRUGS
- Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels
- (2011) Katrina Weston-Green et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects
- (2011) Somayeh Jafari et al. JOURNAL OF NEUROCHEMISTRY
- Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat
- (2011) Goran Jassim et al. PSYCHOPHARMACOLOGY
- Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: An animal model
- (2011) Margaret Hahn et al. SCHIZOPHRENIA RESEARCH
- Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats
- (2010) Katrina Weston-Green et al. BEHAVIOURAL BRAIN RESEARCH
- Effect of Antipsychotic Medications on Glucose and Lipid Levels
- (2010) Parminder S. Chaggar et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes
- (2010) Emilie Lauressergues et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
- (2009) S. M. Stahl et al. ACTA PSYCHIATRICA SCANDINAVICA
- Are Weight Gain and Metabolic Side Effects of Atypical Antipsychotics Dose Dependent?
- (2009) Viktoria Simon et al. JOURNAL OF CLINICAL PSYCHIATRY
- Dyslipidemia in type 2 diabetes mellitus
- (2009) Arshag D Mooradian Nature Reviews Endocrinology
- Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms
- (2009) Gavin P Reynolds et al. PHARMACOLOGY & THERAPEUTICS
- The role of histaminergic H1 and H3 receptors in food intake: A mechanism for atypical antipsychotic-induced weight gain?
- (2009) Chao Deng et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal model
- (2009) Araba F. Chintoh et al. SCHIZOPHRENIA RESEARCH
- Sensitivity of the female rat to olanzapine-induced weight gain—Far from the clinic?
- (2009) Katrina Weston-Green et al. SCHIZOPHRENIA RESEARCH
- Diabetes and schizophrenia – effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia
- (2008) S. Saddichha et al. ACTA PSYCHIATRICA SCANDINAVICA
- Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat
- (2008) G. C. Smith et al. DIABETOLOGIA
- Atypical antipsychotic-induced diabetes mellitus: an update on epidemiology and postulated mechanisms
- (2008) S. Buchholz et al. INTERNAL MEDICINE JOURNAL
- Antipsychotic-induced body weight gain: Predictors and a systematic categorization of the long-term weight course
- (2008) Stefan Gebhardt et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver
- (2008) Johan Fernø et al. PSYCHOPHARMACOLOGY
- Secondary Effects of Antipsychotics: Women at Greater Risk Than Men
- (2008) M. V. Seeman SCHIZOPHRENIA BULLETIN
- Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population
- (2008) Rocio Perez-Iglesias et al. SCHIZOPHRENIA RESEARCH
- Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications
- (2008) Mehrul Hasnain et al. Primary Care Diabetes
- Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: Implications for animal models of antipsychotic-induced weight gain
- (2007) G.D. Cooper et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search